Skip to main content
Clinical Trials/NCT01510340
NCT01510340
Completed
Phase 3

Evaluation of a Tailored Virtual Intervention to Empower Persons Living With HIV for Therapy Self-management

Centre hospitalier de l'Université de Montréal (CHUM)1 site in 1 country217 target enrollmentJanuary 2012
ConditionsHIV

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
HIV
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Enrollment
217
Locations
1
Primary Endpoint
Adherence
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the efficacy of an online virtual intervention in optimizing adherence to antiretroviral medication intake among Persons Living with HIV (PLHIV).

Registry
clinicaltrials.gov
Start Date
January 2012
End Date
June 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • have to be under ART for at least six months¸
  • have internet access

Exclusion Criteria

  • be pregnant
  • active IV drug user
  • actual diagnosis of psychiatric health problem

Outcomes

Primary Outcomes

Adherence

Time Frame: 6 months

Adherence will be evaluated through a self-administered questionnaire that was developed for and validated on the targeted population (Godin, Gagné, \& Naccache, 2003). The questionnaire comprises seven items that serve to determine how many times a person forgets to take his or her medication. The questionnaire's validity was demonstrated (sensitivity: 71 %; specificity: 72%; correct classification: 72%; odds ratio: 6.15) using immunologic (CD4 count) and virologic (viral load) parameters as validation criteria. Adherence is defined as the intake of at least 95% of prescribed tablets.

Study Sites (1)

Loading locations...

Similar Trials